Beyond Meat Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Beyond Meat Inc reported revenue of $275.5M (-15.6% year on year) and net income of $219.0M (+236.7% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net revenues | $275.5M | $326.5M | $343.4M | $418.9M |
| Cost of goods sold | $267.9M | $284.8M | $426.0M | $442.7M |
| Gross profit (loss) | $7.6M | $41.7M | ($82.7M) | ($23.7M) |
| Research and development expenses | $23.2M | $28.1M | $39.5M | $62.3M |
| Selling, general and administrative expenses | $217.8M | $169.7M | $220.3M | $239.5M |
| Loss on write-down of assets held for sale | $49.0M | — | — | — |
| Loss from impairment of long-lived assets | $51.3M | — | — | — |
| Restructuring expenses | $0 | $0 | ($631.0K) | $17.3M |
| Total operating expenses | $341.3M | $197.8M | $259.2M | $319.0M |
| Loss from operations | ($333.6M) | ($156.1M) | ($341.9M) | ($342.8M) |
| Interest expense | ($14.0M) | ($4.1M) | ($4.0M) | ($4.0M) |
| Remeasurement of warrant liability | $15.1M | — | — | — |
| Remeasurement of derivative liability | ($12.3M) | — | — | — |
| Gain on debt restructuring, net of exchange fees | $548.7M | — | — | — |
| Other, net | $15.3M | ($10.0K) | $11.6M | ($420.0K) |
| Total other income (expense), net | $552.7M | ($4.1M) | $7.7M | ($4.4M) |
| Income (loss) before taxes | $219.1M | ($160.2M) | ($334.2M) | ($347.2M) |
| Income tax (benefit) expense | $0 | ($26.0K) | $5.0K | $32.0K |
| Equity in losses of unconsolidated joint venture | $78.0K | $73.0K | $3.9M | $18.9M |
| Net income (loss) | $219.0M | ($160.3M) | ($338.1M) | ($366.1M) |
| Less: Earnings allocated to participating securities | ($41.0M) | — | — | — |
| Net income (loss) available to common stockholders—basic (in shares) | 178.0M | — | — | — |
| Net income (loss) per share available to common stockholders—basic (in dollars per share) | $1.15 | -$2.43 | -$5.26 | -$5.75 |
| Weighted average common shares outstanding—Basic (in shares) | 155.3M | 66.0M | 64.3M | 63.6M |
| Net loss per share available to common stockholders—diluted (in dollars per share) | -$1.83 | -$2.43 | -$5.26 | -$5.75 |
| Weighted average common shares outstanding—diluted (in shares) | 180.9M | 66.0M | 64.3M | 63.6M |
| Line item | Jun 27, 2026 · Q2 | Mar 28, 2026 · Q1 | Sep 27, 2025 · Q3 | Jun 28, 2025 · Q2 |
|---|---|---|---|---|
| Net revenues | $68.8M | $58.2M | $70.2M | $75.0M |
| Cost of goods sold | $63.0M | $56.2M | $63.0M | $66.4M |
| Gross profit | $5.9M | $2.0M | $7.2M | $8.6M |
| Research and development expenses | $4.2M | $5.2M | $4.9M | $5.8M |
| Selling, general and administrative expenses | $32.5M | $37.9M | $37.2M | $37.7M |
| Total operating expenses | $36.7M | $43.1M | $119.6M | $43.5M |
| Loss from operations | ($30.8M) | ($41.1M) | ($112.3M) | ($34.9M) |
| Interest expense | ($6.6M) | ($6.7M) | ($4.4M) | ($2.0M) |
| Remeasurement of delayed draw term loan warrant liability | ($76.0K) | $1.3M | $5.3M | — |
| Remeasurement of derivative liability | ($3.8M) | $11.9M | — | — |
| Gain on debt extinguishment | $57.7M | $6.1M | — | — |
| Other (expense) income, net | ($18.0K) | $119.0K | $750.0K | $7.7M |
| Total other income, net | $47.2M | $12.6M | $1.6M | $5.7M |
| Income (loss) before taxes | $16.4M | ($28.5M) | ($110.7M) | ($29.2M) |
| Income tax expense | $0 | $0 | $0 | $0 |
| Equity in losses of unconsolidated joint venture | $16.0K | $16.0K | $7.0K | $59.0K |
| Net income (loss) | $16.4M | ($28.5M) | ($110.7M) | ($29.2M) |
| Net income (loss) per share available to common stockholders—basic (in dollars per share) | $0.03 | -$0.06 | -$1.44 | -$0.38 |
| Net loss per share available to common stockholders—diluted (in dollars per share) | -$0.06 | -$0.06 | -$1.44 | -$0.38 |
| Weighted average common shares outstanding — basic (in shares) | 501.3M | 455.3M | 76.7M | 76.5M |
| Weighted average common shares outstanding — diluted (in shares) | 591.9M | 455.3M | 76.7M | 76.5M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $203.9M | $131.9M | $190.5M | $309.9M |
| Restricted cash, current | $4.3M | $1.0M | $2.8M | — |
| Accounts receivable, net | $26.1M | $26.9M | $31.7M | $34.2M |
| Inventory | $84.0M | $113.4M | $130.3M | $235.7M |
| Prepaid expenses and other current assets | $13.8M | $11.3M | $12.9M | $20.7M |
| Assets held for sale | $9.4M | $1.9M | $4.5M | $5.9M |
| Total current assets | $341.5M | $286.5M | $372.8M | $606.5M |
| Restricted cash, non-current | $9.3M | $12.6M | $12.6M | $12.6M |
| Property, plant and equipment, net | $213.3M | $184.9M | $194.0M | $257.0M |
| Operating lease right-of-use assets | $5.7M | $124.0M | $130.5M | $87.6M |
| Prepaid lease costs, non-current | $40.9M | $68.0M | $61.6M | $85.5M |
| Other non-current assets, net | $2.6M | $622.0K | $1.2M | $10.7M |
| Investment in unconsolidated joint venture | $1.5M | $1.6M | $1.7M | $2.3M |
| Total assets | $614.7M | $678.1M | $774.5M | $1.1B |
| Accounts payable | $20.5M | $37.6M | $56.0M | $55.3M |
| Current portion of operating lease liabilities | $2.1M | $4.1M | $3.7M | $3.8M |
| Accrued expenses and other current liabilities | $9.0M | $11.9M | $9.9M | $16.7M |
| Accrued litigation expenses | $38.9M | — | — | — |
| Accrued litigation settlement | $0 | $7.3M | — | — |
| Short-term finance lease liabilities | $4.4M | — | — | — |
| Total current liabilities | $74.9M | $61.5M | $74.4M | $75.8M |
| Notes, net | $337.9M | $1.1B | $1.1B | $1.1B |
| Delayed draw term loans, net | $77.9M | — | — | — |
| Delayed draw term loan warrants at fair value | $5.1M | — | — | — |
| Operating lease liabilities, net of current portion | $4.1M | $73.6M | $75.6M | $55.9M |
| Finance lease liabilities | $76.6M | — | — | — |
| 2030 Embedded Derivative liability at fair value | $39.2M | — | — | — |
| Other long-term liabilities | $220.0K | $2.8M | $274.0K | $469.0K |
| Total long-term liabilities | $540.8M | $1.2B | $1.2B | $1.2B |
| Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, par value $0.0001 per share—3,000,000,000 shares and 500,000,000 shares authorized at December 31, 2025 and 2024, respectively; 453,688,312 shares and 76,065,969 shares issued and outstanding at December 31, 2025 and 2024, respectively | $45000.00 | $8000.00 | $6000.00 | $6000.00 |
| Additional paid-in capital | $1.0B | $644.0M | $573.1M | $544.4M |
| Accumulated deficit | ($1.0B) | ($1.2B) | ($1.1B) | ($743.1M) |
| Accumulated other comprehensive loss | ($7.8M) | ($3.7M) | ($5.2M) | ($4.8M) |
| Total stockholders’ deficit | ($997.0K) | ($601.2M) | ($513.4M) | ($203.5M) |
| Total liabilities and stockholders’ deficit | $614.7M | $678.1M | $774.5M | $1.1B |
| Line item | Jun 27, 2026 | Mar 28, 2026 | Sep 27, 2025 | Jun 28, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $171.4M | $191.0M | $117.3M | $103.5M |
| Restricted cash, current | $5.5M | $4.3M | $1.2M | $1.2M |
| Accounts receivable, net | $25.7M | $25.9M | $27.9M | $37.3M |
| Inventory | $63.1M | $68.9M | $110.3M | $110.9M |
| Prepaid expenses and other current assets | $21.2M | $11.2M | $31.0M | $42.6M |
| Assets held for sale | $8.7M | $9.6M | $910.0K | $1.7M |
| Total current assets | $295.6M | $311.0M | $288.6M | $297.1M |
| Restricted cash, non-current | $9.3M | $10.4M | $12.6M | $12.6M |
| Property, plant, and equipment, net | $201.7M | $207.5M | $254.4M | $321.0M |
| Operating lease right-of-use assets | $4.6M | $5.2M | $5.2M | $6.5M |
| Prepaid lease costs, non-current | $42.5M | $41.2M | $35.7M | $52.3M |
| Other non-current assets, net | $4.7M | $2.8M | $1.6M | $688.0K |
| Investment in unconsolidated joint venture | $1.5M | $1.5M | $1.5M | $1.5M |
| Total assets | $559.9M | $579.5M | $599.7M | $691.7M |
| Accounts payable | $25.0M | $22.6M | $46.1M | $68.8M |
| 2027 Notes | $29.5M | $29.5M | — | — |
| Current portion of operating lease liabilities | $2.2M | $2.1M | $1.8M | $1.8M |
| Accrued expenses and other current liabilities | $12.7M | $11.7M | $11.2M | $15.6M |
| Accrued litigation expenses | $38.9M | $38.9M | — | — |
| Short-term finance lease liabilities | $4.0M | $4.2M | $4.6M | $3.9M |
| Total current liabilities | $112.2M | $109.0M | $63.6M | $90.2M |
| Notes, net | $208.7M | $300.5M | $1.1B | $1.1B |
| Delayed draw term loans, net | $85.6M | $81.7M | $77.7M | $30.5M |
| Delayed draw term loan warrants at fair value | $3.8M | $3.8M | $14.8M | $20.1M |
| Operating lease liabilities, net of current portion | $3.1M | $3.5M | $4.0M | $4.4M |
| Finance lease liabilities | $74.8M | $75.7M | — | — |
| 2030 Notes Embedded Derivative liability at fair value | $14.6M | $26.1M | — | — |
| Other long-term liabilities | $220.0K | $222.0K | $79.1M | $80.0M |
| Total long-term liabilities | $390.9M | $491.5M | $1.3B | $1.3B |
| Preferred stock, par value $0.0001 per share — 500,000 shares authorized, none issued and outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, par value $0.0001 per share — 3,000,000,000 shares authorized; 515,793,219 shares and 453,688,312 shares issued and outstanding at June 27, 2026 and December 31, 2025, respectively | $52000.00 | $46000.00 | $8000.00 | $8000.00 |
| Additional paid-in-capital | $1.1B | $1.0B | $657.5M | $653.9M |
| Accumulated deficit | ($1.0B) | ($1.1B) | ($1.4B) | ($1.3B) |
| Accumulated other comprehensive loss | ($4.8M) | ($7.5M) | ($7.2M) | ($7.2M) |
| Total stockholders’ equity (deficit) | $56.8M | ($21.1M) | ($784.1M) | ($677.0M) |
| Total liabilities and stockholders' equity (deficit) | $559.9M | $579.5M | $599.7M | $691.7M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $219.0M | ($160.3M) | ($338.1M) | ($366.1M) |
| Loss from impairment of long-lived assets | $51.3M | — | — | — |
| Depreciation and amortization | $32.8M | $23.1M | $48.1M | $32.6M |
| Non-cash lease expense | $4.0M | $8.3M | $8.1M | $5.2M |
| Share-based compensation expense | $31.0M | $23.9M | $29.1M | $33.9M |
| Provision for credit losses | $1.0K | $221.0K | — | — |
| Amortization of debt issuance costs and debt discount | $5.0M | — | — | — |
| Loss on write-down and sale of fixed assets | $49.3M | — | — | — |
| Equity in losses of unconsolidated joint venture | $78.0K | $73.0K | $3.9M | $18.9M |
| Remeasurement of warrant liability | ($15.1M) | — | — | — |
| Change in derivative liability | $12.3M | — | — | — |
| Write-down of note receivable | $136.0K | $0 | $3.8M | — |
| Gain on debt restructuring, net of exchange fees | ($557.9M) | — | — | — |
| Unrealized (gains) losses on foreign currency transactions | ($12.1M) | $5.1M | $1.8M | $5.1M |
| Paid-in-kind interest | $4.6M | — | — | — |
| Accounts receivable | $1.6M | $4.2M | $2.7M | $9.1M |
| Inventories | $31.7M | $15.6M | $106.1M | $2.6M |
| Prepaid expenses and other current assets | ($4.9M) | $2.0M | $12.9M | $11.6M |
| Accounts payable | ($15.2M) | ($20.6M) | $3.0M | ($10.8M) |
| Accrued expenses and other current liabilities | $28.8M | $4.5M | ($2.5M) | ($7.1M) |
| Prepaid lease costs, non-current | ($8.3M) | ($6.5M) | ($4.2M) | ($55.1M) |
| Operating lease liabilities | ($3.2M) | ($3.2M) | ($3.3M) | ($4.3M) |
| Long-term liabilities | $220.0K | — | — | — |
| Net cash used in operating activities | ($144.9M) | ($98.8M) | ($107.8M) | ($320.2M) |
| Purchases of property, plant and equipment | ($12.3M) | ($11.0M) | ($10.6M) | ($70.5M) |
| Proceeds from sale of fixed assets | $1.9M | $4.3M | $4.3M | — |
| Proceeds from note receivable on assets previously held for sale | $84.0K | — | — | $0 |
| Payments for investment in joint venture | $0 | $0 | ($3.3M) | ($13.3M) |
| Proceeds from security deposits | $32.0K | $435.0K | — | — |
| Net cash used in investing activities | ($10.3M) | ($6.2M) | ($9.5M) | ($87.5M) |
| Proceeds from issuance of common stock pursuant to the ATM Program, net of issuance costs | $148.7M | $46.7M | — | — |
| Proceeds from delayed draw term loans, net of issuance costs | $100.0M | — | — | — |
| Payment of debt issuance costs | ($15.6M) | — | $0 | $0 |
| Payment of equity issuance costs | ($6.5M) | — | — | — |
| Principal payments under finance lease obligations | ($2.7M) | ($1.2M) | ($223.0K) | ($210.0K) |
| Proceeds from exercise of stock options | $6.0K | $924.0K | $170.0K | $1.6M |
| Payments of minimum withholding taxes on net share settlement of equity awards | ($424.0K) | ($695.0K) | ($497.0K) | ($1.1M) |
| Net cash provided by (used in) financing activities | $223.4M | $45.8M | ($550.0K) | $276.0K |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $68.2M | ($59.3M) | ($117.9M) | ($407.5M) |
| Cash, cash equivalents and restricted cash at the beginning of the period | $145.6M | $205.9M | $322.5M | $733.3M |
| Effect of foreign currency exchange rate changes on cash | $3.7M | ($1.1M) | $1.3M | ($3.3M) |
| Cash, cash equivalents and restricted cash at the end of the period | $217.5M | $145.6M | $205.9M | $322.5M |
| Interest | $0 | $0 | $0 | $10.0K |
| Taxes | $0 | $6.0K | ($1.0K) | $38.0K |
| Issuance of common stock in conjunction with the exchange of 2027 Notes | $214.6M | — | — | — |
| Line item | Jun 27, 2026 · YTD | Mar 28, 2026 · Q1 | Sep 27, 2025 · YTD | Jun 28, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | ($12.1M) | ($28.5M) | ($192.8M) | ($82.2M) |
| Depreciation and amortization | $13.5M | $6.8M | $25.0M | $15.7M |
| Non-cash lease expense | $985.0K | $491.0K | $3.3M | $2.9M |
| Share-based compensation expense | $13.9M | $6.5M | $13.9M | $10.2M |
| Amortization of debt issuance costs and debt discount | $3.7M | $2.0M | — | — |
| Loss on sale and write-down of fixed assets | $162.0K | $30.0K | $128.0K | $223.0K |
| Equity in losses of unconsolidated joint venture | $32.0K | $16.0K | $77.0K | $70.0K |
| Remeasurement of delayed draw term loan warrant liability | ($1.2M) | ($1.3M) | ($5.3M) | — |
| Remeasurement of derivative liability | ($8.1M) | ($11.9M) | — | — |
| Gain on debt extinguishment | ($63.8M) | ($6.1M) | — | — |
| Unrealized losses (gains) on foreign currency transactions | $3.1M | $1.5M | ($11.2M) | ($11.2M) |
| Paid-in-kind interest | $6.3M | $3.1M | $1.5M | — |
| Accounts receivable | $168.0K | ($20.0K) | ($38.0K) | ($9.3M) |
| Inventories | $20.6M | $14.9M | $5.3M | $4.7M |
| Prepaid expenses and other current assets | ($8.5M) | $2.3M | ($1.3M) | ($8.5M) |
| Accounts payable | $5.1M | $2.3M | ($1.4M) | $25.7M |
| Accrued expenses and other current liabilities | $4.0M | $2.8M | ($7.8M) | ($3.6M) |
| Prepaid lease costs, non-current | ($155.0K) | $628.0K | ($5.1M) | ($3.9M) |
| Operating lease liabilities | ($918.0K) | ($543.0K) | ($2.6M) | ($2.2M) |
| Net cash used in operating activities | ($23.2M) | ($5.0M) | ($98.1M) | ($59.4M) |
| Purchases of property, plant and equipment | ($4.0M) | ($2.5M) | ($9.3M) | ($6.4M) |
| Proceeds from sales of fixed assets | $1.9M | $1.0M | $1.3M | $348.0K |
| Payments of security deposits | ($204.0K) | ($257.0K) | $0 | $0 |
| Net cash used in investing activities | ($2.3M) | ($1.8M) | ($8.0M) | ($6.1M) |
| Proceeds from delayed draw term loan | $0 | — | $100.0M | $40.0M |
| Payments of debt issuance costs | $0 | $0 | ($10.3M) | ($5.1M) |
| Principal payments under finance lease obligations | ($3.6M) | ($843.0K) | ($1.5M) | ($937.0K) |
| Proceeds from exercise of stock options | $0 | — | $6.0K | $6.0K |
| Payments of minimum withholding taxes on net share settlement of equity awards | ($3.0M) | ($2.7M) | ($385.0K) | ($312.0K) |
| Net cash (used in) provided by financing activities | ($6.6M) | ($4.5M) | $87.8M | $33.6M |
| Effect of foreign currency exchange rate changes on cash | $668.0K | ($468.0K) | $3.8M | $3.5M |
| Net decrease in cash, cash equivalents and restricted cash | ($31.4M) | ($11.3M) | ($18.3M) | ($31.8M) |
| Cash, cash equivalents and restricted cash at the beginning of the period | $217.5M | $217.5M | $145.6M | $145.6M |
| Cash, cash equivalents and restricted cash at the end of the period | $186.1M | $205.8M | $131.1M | $117.3M |
| Taxes | $0 | $0 | $2.0K | $2.0K |
| Conversion of 2030 Notes by issuance of common stock | $54.6M | $4.2M | — | — |
| Issuance of delayed draw term loan warrants | $0 | — | $20.4M | $20.1M |
| Non-cash additions to property, plant and equipment | $161.0K | $471.0K | $676.0K | $1.3M |
| Operating lease right-of-use assets obtained in exchange for lease liabilities | $83.0K | — | $1.9M | $2.1M |
| Reclassification of pre-paid lease costs to finance lease right-of-use assets | $0 | — | $19.9M | $19.9M |
| Non-cash additions to finance leases | $0 | $0 | $10.2M | $10.1M |
Beyond Meat Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.